Depressive Disorder, Treatment-Resistant

44 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Depressive Disorder, Treatment-Resistant
Treatment and conditionWhere it standsTrials
(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Abbott Laboratories Infinity™ implantable deep brain stimulation system for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Accelerated theta-burst stimulation treatment for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Activa Tremor Control Sys (DBS Implant) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
active rTMS treatment for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Behavioural Activation (BA) Therapy for depressive disorder, treatment-resistantTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Bilateral implantation of DBS system to Habeluna for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BPL-003 for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Deep Brain Stimulation for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation (DBS) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation Model 3387 Model 3389 for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
deep brain stimulation with short & long pulse width for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation, implanted for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep brain stimulation(Active) + Deep brain stimulation(Sham) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation(DBS) + Esketamine for depressive disorder, treatment-resistantPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Device: Directional Deep Brain Stimulation for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
edupression.com® for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Emono for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Escitalopram + Esketamine + Venlafaxine + Duloxetine + SERTRALINE for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Esketamine for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Esketamine Treatment as Usual (ESK) + Virtual-Reality-based mindfulness intervention for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Integration Therapy for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ketamine Hydrochloride for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Medtronic Activa PC+S System for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Activa SC DBS, Lead Model 3387 for depressive disorder, treatment-resistantTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Percept PC DBS system for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic SenSight Directional DBS lead for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Summit RC+S DBS system for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mindfulness-centered psilocybin-assisted therapy + Music-centered psilocybin-assisted therapy + Psilocybin for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nitrous Oxide for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Oculus VR headset for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Olanzapine and Fluoxetine combination (OFC) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Escitalopram + Venlafaxine + Duloxetine + SERTRALINE for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo of trazodone + Psilocybin for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)8
Randomized, staggered withdrawal phase for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
SSRI/SNRI + Esketamine for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
tDCS for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Trazodone 5mg + Psilocybin for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1